Antiverse raises £3.5 M ($4.6 M) to advance generative AI antibody design platform

Antiverse, a techbio company designing antibodies for challenging targets, today announced it has added £3.5 M ($4.6 M) to its seed funding.

FDA Gives Nod to Gene Therapy for Hemophilia A

The FDA approved valoctocogene roxaparvovec (Roctavian) as the first gene therapy for the treatment of adults with severe hemophilia A, drug developer Biomarin announced on

June 30, 2023

Novavax and Gavi end a bitter dispute over Covid-19 vaccines with a refund up to $400 million

After a contentious dispute, Novavax has agreed to refund up to $400 million to the international organization that purchased Covid-19 shots as part of a

February 22, 2024

Racing for gene therapy, a pioneering approval, & startups in the lurch

What difference does a day make? Who gets to have gene therapy? And are biotech startups OK? We cover all that and more this week

August 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.